Sister chromatid exchanges in Down syndromes and normal human beings. 1977

E A Lezana, and N O Bianchi, and M S Bianchi, and J E Zabala-Suarez

The BrdU-Giemsa method was used to analyze the frequency of SCEs in a group of five Down syndromes and in a group of five normal human beings. In total 25 second mitoses were scored for SCEs in each individual. Although Down syndromes exhibited a tendency to have higher rates of exchange than normal human beings the analysis of variance showed that these differences were not statistically significant. On the other hand, significant differences were observed in the rates of SCEs between individuals within each group. This variability may reflect inter-individual differences in the efficiency of the mechanisms involved in the production of exchanges. The frequency of SCEs in blood cultures in probably the average of the rates exhibited by two or more lymphocyte sub-populations with different sensitivities to BrdU. Hence, the variability in the rate of exchange between different cultures of the same individual probably arises by changes in the percentage of cells in the second mitosis deriving from each lymphocyte sub-population.

UI MeSH Term Description Entries
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008297 Male Males
D001973 Bromodeoxyuridine A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors. BUdR,BrdU,Bromouracil Deoxyriboside,Broxuridine,5-Bromo-2'-deoxyuridine,5-Bromodeoxyuridine,NSC-38297,5 Bromo 2' deoxyuridine,5 Bromodeoxyuridine,Deoxyriboside, Bromouracil
D002842 Chromatids Either of the two longitudinally adjacent threads formed when a eukaryotic chromosome replicates prior to mitosis. The chromatids are held together at the centromere. Sister chromatids are derived from the same chromosome. (Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Chromatid
D003434 Crossing Over, Genetic The reciprocal exchange of segments at corresponding positions along pairs of homologous CHROMOSOMES by symmetrical breakage and crosswise rejoining forming cross-over sites (HOLLIDAY JUNCTIONS) that are resolved during CHROMOSOME SEGREGATION. Crossing-over typically occurs during MEIOSIS but it may also occur in the absence of meiosis, for example, with bacterial chromosomes, organelle chromosomes, or somatic cell nuclear chromosomes. Crossing Over,Crossing-Over, Genetic,Crossing Overs,Genetic Crossing Over,Genetic Crossing-Over
D004314 Down Syndrome A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213) Mongolism,Trisomy 21,47,XX,+21,47,XY,+21,Down Syndrome, Partial Trisomy 21,Down's Syndrome,Partial Trisomy 21 Down Syndrome,Trisomy 21, Meiotic Nondisjunction,Trisomy 21, Mitotic Nondisjunction,Trisomy G,Downs Syndrome,Syndrome, Down,Syndrome, Down's
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001399 Azure Stains PHENOTHIAZINES with an amino group at the 3-position that are green crystals or powder. They are used as biological stains. Giemsa Stain,Giemsa-11,Giemsa 11,Stain, Giemsa,Stains, Azure
D014644 Genetic Variation Genotypic differences observed among individuals in a population. Genetic Diversity,Variation, Genetic,Diversity, Genetic,Diversities, Genetic,Genetic Diversities,Genetic Variations,Variations, Genetic

Related Publications

E A Lezana, and N O Bianchi, and M S Bianchi, and J E Zabala-Suarez
January 1980, Advances in human genetics,
E A Lezana, and N O Bianchi, and M S Bianchi, and J E Zabala-Suarez
May 1979, Genetics,
E A Lezana, and N O Bianchi, and M S Bianchi, and J E Zabala-Suarez
February 1982, Mutation research,
E A Lezana, and N O Bianchi, and M S Bianchi, and J E Zabala-Suarez
August 1976, Cancer research,
E A Lezana, and N O Bianchi, and M S Bianchi, and J E Zabala-Suarez
May 1992, Experientia,
E A Lezana, and N O Bianchi, and M S Bianchi, and J E Zabala-Suarez
January 1981, Human genetics,
E A Lezana, and N O Bianchi, and M S Bianchi, and J E Zabala-Suarez
February 1974, Experimental cell research,
E A Lezana, and N O Bianchi, and M S Bianchi, and J E Zabala-Suarez
January 1985, Przeglad lekarski,
E A Lezana, and N O Bianchi, and M S Bianchi, and J E Zabala-Suarez
October 1977, The Journal of investigative dermatology,
E A Lezana, and N O Bianchi, and M S Bianchi, and J E Zabala-Suarez
July 1984, Lancet (London, England),
Copied contents to your clipboard!